Valneva

Valneva P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Valneva (VLA.PA) as of Oct 19, 2026 is -14.92. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -11.74 — a change of 27.08% (lower).

P/CF

-14.92

YoY

27.08%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Valneva is 2025 -14.92 . P/CF (Price-to-Cash-Flow Ratio) of Valneva was 2024 -11.74 . It decreases by 27.08% lower compared to the previous year.

The Valneva P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
48.39 EUR
Jan 1, 2019
142.70 EUR
Jan 1, 2020
5.73 EUR
Jan 1, 2021
10.26 EUR
Jan 1, 2022
-3.22 EUR
Jan 1, 2023
-3.89 EUR
Jan 1, 2024
-11.74 EUR
Jan 1, 2025
-14.92 EUR
The Valneva P/CF history
YEARP/CFYoY
-14.92+27.08%
-11.74+201.62%
-3.89+21.01%
-3.22-131.34%
10.26+79.11%
5.73-95.99%
142.70+194.92%
48.39-21.32%
61.50-49.29%
121.29-474.08%
-32.42-38.59%
-52.80—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

P/CF (Price-to-Cash-Flow Ratio) of Valneva is -14.92 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Valneva changed from -11.74 to -14.92, representing a 27.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Valneva since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Valneva with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Valneva

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Valneva